Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atovaquone vs Dapsone for PCP Prophylaxis in HIV
NCT00000802Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of atovaquone in Pneumocystis jirovecii pneumonia (PJP), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
atovaquone
03
Conditions
Pneumocystis jirovecii pneumonia (PJP)
Beyond the preview
Go deeper on NCT00000802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000802.